​

Funding Round

Series B - NMD Pharma

Series B - NMD Pharma

Investment Firm

Overview

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Announced Date

Nov 15, 2023

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Jeito Capital

Jeito Capital

Jeito Capital is a early_stage_venture and late_stage_venture firm.

Participant Investors

5

Investor Name
Participant InvestorLundbeckfonden Emerge
Participant InvestorJeito Capital
Participant InvestorInkef
Participant InvestorNovo Holdings
Participant InvestorRoche Venture Fund

Round Details and Background

NMD Pharma raised $81409005 on 2023-11-15 in Series B

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 23, 2018
Series A - NMD Pharma
4-47.0M
Jan 01, 2016
Grant - NMD Pharma
1-358.3K
Feb 15, 2022
Venture Round - NMD Pharma
5-39.7M
Nov 15, 2023
Series B - NMD Pharma
5-81.4M

Recent Activity

There is no recent news or activity for this profile.